Skip to main content
. Author manuscript; available in PMC: 2021 Dec 1.
Published in final edited form as: Pain. 2020 Dec;161(12):2860–2871. doi: 10.1097/j.pain.0000000000001996

Table 1.

CPPC study demographic and patient characteristics.

Males [N] Females [N] Total [N] F/M P-value
CPPC
EM 18 245 263 2.3x < 0.01
TMD 10 162 172 2.7x < 0.01
IBS 20 201 221 1.7x 0.02
FM 2 94 96 7.8x < 0.01
VVS 0 100 100 N/A N/A
ANY 30 342 372 1.9x < 0.01
CTL 57 180 237 0.5x < 0.01
# CPPCs
0 57 180 237 0.5x < 0.01
1 19 123 142 1.1x 0.90
2 3 49 52 2.7x 0.10
3 7 115 122 2.7x < 0.01
4 1 39 40 6.5x 0.04
5 0 16 16 N/A N/A
Ancestry
Cauc 55 366 421 1.1x 0.53
Af-Am 25 117 142 0.8x 0.28
Other 7 39 46 0.9x 0.83
Age [y] 34.6 (±11.9) 36.2 (±11.6) 36.0 (±11.6) 1.05x 0.61
min/max 18/61 18/64 18/64
Counts 87 522 609

Distribution of CPPCs and characteristics in males and in females. Participants can report more than one chronic pain conditions, therefore the counts in each sex is higher than the total number of individuals in the cohort. All P-values obtained using exact Fisher test, except for age, using Welch’s two-sample unequal variance. Complex persistent pain conditions were: episodic migraine, EM; temporomandibular disorders, TMD; irritable bowel syndrome, IBS; fibromyalgia, FM; vulvar vestibulitis, VVS; any of preceding, ANY; or controls, CTL. Number of CPPCs (#) in any study participant range from 0 to 5, inclusively. Ancestries were: Caucasians, Cauc; African-Americans, Af-Am; and others.